METHOD OF DETERMINING A SUBSTRATE IN A SAMPLE.
    41.
    发明公开
    METHOD OF DETERMINING A SUBSTRATE IN A SAMPLE. 失效
    一种确定基材在一个样本。

    公开(公告)号:EP0035521A4

    公开(公告)日:1982-02-16

    申请号:EP80901703

    申请日:1981-03-23

    发明人: DUFFY PATRICK

    摘要: Method of determining a substrate in a sample which comprises converting the substrate to a product in a first stage of a cyclic reaction sequence and converting the product back to the substrate in a second reaction stage of the cyclic reaction sequence. At least one of the first and second reaction stages is enzyme catalyzed. Simultaneously with either the first reaction stage or the second reaction stage an indicating substrate is convened to an indicating product in a non-reversible indicator reaction. After this the loss of indicating substract or gain of indicating product may be determined. The method is particularly efficacious in enzyme immunoassay determinations which include homogeneous enzyme immunoassay and enzyme linked immunoassay wherein the free or bound enzyme-ligand or enzyme antibody conjugate is to be assayed by the method of the invention.

    COMPOUNDS AND METHODS OF IDENTIFYING, SYNTHESIZING, OPTIMIZING AND PROFILING PROTEIN MODULATORS

    公开(公告)号:EP4424838A2

    公开(公告)日:2024-09-04

    申请号:EP24174492.9

    申请日:2006-11-24

    申请人: Housey, Gerard M.

    发明人: Housey, Gerard M.

    IPC分类号: C12Q1/50

    摘要: This invention relates to methods of identifying, synthesizing, optimizing and profiling compounds that are inhibitors or activators of proteins, both naturally occurring endogenous proteins as well as certain variant forms of endogenous proteins, and novel methods of identifying such variants. The method accelerates the identification and development of compounds as potential therapeutically effective drugs by simplifying the pharmaceutical discovery and creation process through improvements in hit identification, lead optimization, biological profiling, and rapid elimination of toxic compounds. Implementation results in overall cost, reductions in the drug discovery process resulting from the corresponding increases in efficiency.

    METHOD FOR ASSAYING VITAL SAMPLE
    47.
    发明公开
    METHOD FOR ASSAYING VITAL SAMPLE 失效
    VERFAHREN ZUR BESTIMMUNG VON VITALPROBEN

    公开(公告)号:EP0881301A4

    公开(公告)日:2004-12-08

    申请号:EP96941190

    申请日:1996-12-06

    CPC分类号: C12Q1/48 C12Q1/527

    摘要: A method for determining ADP contained in a liquid sample by means of an enzymatic reaction, which comprises reacting the sample at 15 to 45 DEG C at least in the presence of glucose, ADP-dependent hexokinase, and oxidized NAD(P), a glucose-6-phosphate anhydrase, and one or more salts releasing ions selected among magnesium, cobalt, and manganese ions and then determining the ADP contained in the sample together with the AMP resulting from the reaction based on the amount of the reduced NAD(P) yielded. This method has advantages in that the limit of determination is high because ADP is determined based on the amount of the reduced NAD(P) yielded, and that since the reduced NAD(P) has a definite molecular extinction coefficient, the found value is highly reliable and uninfluenced by the reducing substances, etc., contained in the sample.

    摘要翻译: 一种通过酶反应测定在液体样品中含有ADP的方法,该方法包括至少在存在葡萄糖,ADP依赖性己糖激酶和氧化的NAD(P)的情况下使样品在15至45℃下反应,葡萄糖 -6-磷酸脱氢酶和一种或多种释放从镁,钴和锰离子中选出的离子的盐,然后基于还原的NAD(P)的量来确定样品中包含的ADP与由反应产生的AMP一起, 产生。 该方法的优点在于,由于ADP是通过还原的NAD(P)产生量决定的,所以测定的极限很高,而且由于还原的NAD(P)具有确定的分子消光系数,所以发现值高 可靠且不受样品中所含的还原物质等的影响。

    ENZYMATIC COMPOSITION FOR CLINICAL EXAMINATION
    48.
    发明公开
    ENZYMATIC COMPOSITION FOR CLINICAL EXAMINATION 失效
    酶组合用于临床检查

    公开(公告)号:EP0791658A4

    公开(公告)日:2000-10-04

    申请号:EP95936772

    申请日:1995-11-10

    摘要: Disclosed is a stabilized enzyme composition for use in clinical examination, comprising: (a) an enzyme component comprising at least two enzymes selected from the group consisting of alkaline phosphatase, creatine kinase and alanine aminotransferase; (b) a stabilizer component comprising effective stabilizing amounts of an albumin, and at least one saccharide selected from the group consisting of trehalose and sorbitol; and (c) an aqueous medium having dissolved therein the components (a) and (b). The enzyme composition of the present invention is stable for a prolonged period of time not only under non-freeze refrigeration conditions, but also under freezing conditions or under conditions for non-freeze refrigeration after thawing of the frozen composition, as compared to the conventional enzymatic compositions. The enzyme composition of the present invention can be advantageously used for the purpose of checking the precision in measurement, correcting measured values and calibrating the amount and activity of an enzyme, in a clinical examination for measuring the enzymatic activity in a sample, such as serum or the like.

    STABILISIERTES REAGENZ UND VERFAHREN ZUR BESTIMMUNG VON CREATIN-KINASE
    49.
    发明公开
    STABILISIERTES REAGENZ UND VERFAHREN ZUR BESTIMMUNG VON CREATIN-KINASE 有权
    稳定化试剂,用于确定肌酸激酶

    公开(公告)号:EP1038024A1

    公开(公告)日:2000-09-27

    申请号:EP98966274.7

    申请日:1998-12-09

    IPC分类号: C12Q1/50

    CPC分类号: C12Q1/50

    摘要: A stabilised reagent for photometric enzymatic determination of creatine kinase (CK) in biological sample material by forming ATP from creatine phosphate and ADP and detection of the ATP thus formed containing an organic or inorganic sulphur compound, preferably with a molar deficiency in relation to the added CK activator. A corresponding reagent remains stable at 2-8 °C for up to 12 months without incurring any significant functional loss.

    Flüssigreagenz für den Nachweis von Kreatinkinase
    50.
    发明公开
    Flüssigreagenz für den Nachweis von Kreatinkinase 有权
    液体试剂用于检测肌酸激酶

    公开(公告)号:EP1013774A2

    公开(公告)日:2000-06-28

    申请号:EP99124783.4

    申请日:1999-12-14

    IPC分类号: C12Q1/50 C12Q1/48 C12Q1/32

    CPC分类号: C12Q1/50

    摘要: Flüssigreagenz zum Nachweis von Kreatinkinase-Aktivität, in dem zumindest folgende Substanzen enthalten sind: G6PDH, Hexokinase, Kreatinphosphat, Glukose, ADP, NAD(P) und Thioglycerol, wobei die Substanzen auf zwei separate Reagenzansätze aufgeteilt sind und die Reagenzansätze für den Nachweis miteinander vermischt werden, dadurch gekennzeichnet, daß G6PDH in dem einem Ansatz und Thioglycerol mit mindestens einer weiteren Substanz in dem anderen Ansatz enthalten ist:

    摘要翻译: 用于检测肌酸激酶活性的,其中以下物质至少液体试剂包括:G6PDH,己糖激酶,磷酸肌酸,葡萄糖,ADP,NAD(P)和硫甘油,与物质被分为试剂的两个独立批次和试剂的批次用于检测混合在一起 的特征在于,所述在G6PDH一个方法中,与硫代甘油附带在不同的方法的至少一种其它物质: